GHK-Cu / KPV
GHK-Cu / KPV, 50mg / 20mg. A copper-binding tripeptide with the alpha-MSH C-terminal tripeptide. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This is a blend. GHK-Cu and KPV are combined in a single 70 mg vial at 50 mg and 20 mg respectively. GHK-Cu is a copper-binding tripeptide studied in skin-remodelling and matrix research; KPV is the C-terminal tripeptide of α-MSH studied for NF-κB pathway suppression. The pairing places a matrix-remodelling arm and an inflammatory-signalling arm in one vial. The combination has not been characterised as a single formulation.
GHK-Cu is a copper-binding tripeptide. Collagen and glycosaminoglycan synthesis endpoints are characterised in dermal fibroblast culture, alongside copper-transport activity.
KPV is the C-terminal tripeptide of α-MSH. Lower NF-κB and MAP-kinase pathway activation is measured in vitro at nanomolar concentrations, alongside reduced TNF-α and IL-6 secretion.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | GHK-Cu / KPV |
| Category | Peptide Blends |
| Lot Number | MBP-7438 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!